| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Fluidigm Corporation (NASDAQ: FLDM)
FLDM Technical Analysis
5
| As on 27th May 2022 FLDM SHARE Price closed @ 2.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.78 & Strong Sell for SHORT-TERM with Stoploss of 6.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FLDMSHARE Price
| Open | 2.02 | Change | Price | % |
| High | 2.13 | 1 Day | 0.01 | 0.50 |
| Low | 1.86 | 1 Week | -0.16 | -7.31 |
| Close | 2.03 | 1 Month | -1.83 | -47.41 |
| Volume | 1400057 | 1 Year | -4.36 | -68.23 |
| 52 Week High 7.41 | 52 Week Low 1.68 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FLDM Daily Charts |
FLDM Intraday Charts |
Whats New @ Bazaartrend |
FLDM Free Analysis |
|
|
FLDM Important Levels Intraday
| RESISTANCE | 2.55 |
| RESISTANCE | 2.38 |
| RESISTANCE | 2.28 |
| RESISTANCE | 2.18 |
| SUPPORT | 1.88 |
| SUPPORT | 1.78 |
| SUPPORT | 1.68 |
| SUPPORT | 1.51 |
FLDM Forecast April 2024
| 4th UP Forecast | 5.58 |
| 3rd UP Forecast | 4.44 |
| 2nd UP Forecast | 3.74 |
| 1st UP Forecast | 3.03 |
| 1st DOWN Forecast | 1.03 |
| 2nd DOWN Forecast | 0.32 |
| 3rd DOWN Forecast | -0.38 |
| 4th DOWN Forecast | -1.52 |
FLDM Weekly Forecast
| 4th UP Forecast | 4.40 |
| 3rd UP Forecast | 3.64 |
| 2nd UP Forecast | 3.17 |
| 1st UP Forecast | 2.70 |
| 1st DOWN Forecast | 1.36 |
| 2nd DOWN Forecast | 0.89 |
| 3rd DOWN Forecast | 0.42 |
| 4th DOWN Forecast | -0.34 |
FLDM Forecast2024
| 4th UP Forecast | 13.34 |
| 3rd UP Forecast | 9.71 |
| 2nd UP Forecast | 7.47 |
| 1st UP Forecast | 5.23 |
| 1st DOWN Forecast | -1.17 |
| 2nd DOWN Forecast | -3.41 |
| 3rd DOWN Forecast | -5.65 |
| 4th DOWN Forecast | -9.28 |
Fluidigm Corporation ( NASDAQ USA Symbol : FLDM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FLDM Business Profile
Fluidigm Corporation creates, manufactures, and markets technologies and life sciences tools worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, Hyperion tissue imager, and flow conductor; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. Fluidigm Corporation sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Fluidigm Corporation has a collaboration agreement with the Karolinska Institutet for research applications and product development utilizing CyTOF XT. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California. Address: 2 Tower Place, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service